tetraethylammonium has been researched along with Neurotic Disorders in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CAMPIONI, T | 1 |
| SIMARRO PUIG, J | 1 |
2 other studies available for tetraethylammonium and Neurotic Disorders
| Article | Year |
|---|---|
[Therapeutic study of glutamic acid combined with a new organic phosphorus compound, ditetraethylammonium phosphate].
Topics: Diet, Reducing; Glutamates; Glutamic Acid; Intellectual Disability; Neurotic Disorders; Organophosph | 1954 |
[Tetraethylammonium in psychiatric therapy, especially neurosis].
Topics: Humans; Neurotic Disorders; Tetraethylammonium | 1952 |